Albert Chon
Overview
Albert Chon is a prominent angel investor and the co-founder and Chief Technology Officer (CTO) of Injective Protocol, a decentralized finance (DeFi) platform. As CTO, Chon has been instrumental in developing Injective Protocol, which aims to provide a fully decentralized exchange protocol for cross-chain derivatives trading. In addition to his role at Injective, Chon has made personal investments in several startups, including Level, Nectar AI, and Infrared Finance, focusing on early-stage companies in the technology and financial sectors.
Investment Focus
- Innovative technology solutions
- Strong founding teams
- Scalable business models
Portfolio Companies
Reach Albert Chon directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Albert Chon
What sectors does Albert Chon invest in?
Albert Chon invests in Financial Services, Technology, Cryptocurrency, Blockchain and DeFi, and is based in New York, United States. Albert Chon is listed as a angel investor in the ConnectSafely investor database.
What stage does Albert Chon invest at?
Albert Chon backs companies at Seed, Early Stage and Series A, writing cheques of 100K - 5M.
Which regions does Albert Chon invest in?
Albert Chon invests across United States and Global.
What companies has Albert Chon invested in?
Albert Chon's portfolio includes Nectar AI, Level and Infrared Finance.
Last updated · Source: ConnectSafely investor database
